CARUSO, IRENE
 Distribuzione geografica
Continente #
NA - Nord America 1.050
AS - Asia 653
EU - Europa 543
SA - Sud America 180
AF - Africa 54
OC - Oceania 3
Totale 2.483
Nazione #
US - Stati Uniti d'America 1.000
SG - Singapore 280
BR - Brasile 143
IT - Italia 134
CN - Cina 92
HK - Hong Kong 88
RU - Federazione Russa 76
FR - Francia 66
GB - Regno Unito 54
VN - Vietnam 54
DE - Germania 53
SE - Svezia 42
FI - Finlandia 41
IN - India 34
CA - Canada 29
NL - Olanda 28
ID - Indonesia 19
EG - Egitto 18
MX - Messico 15
BD - Bangladesh 14
CI - Costa d'Avorio 14
PL - Polonia 12
AT - Austria 11
AR - Argentina 10
IQ - Iraq 10
TR - Turchia 10
JP - Giappone 9
EC - Ecuador 8
ZA - Sudafrica 6
CO - Colombia 5
CZ - Repubblica Ceca 5
MY - Malesia 5
PH - Filippine 5
IE - Irlanda 4
PK - Pakistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
JM - Giamaica 3
LB - Libano 3
LT - Lituania 3
NG - Nigeria 3
NP - Nepal 3
PE - Perù 3
UZ - Uzbekistan 3
CL - Cile 2
DZ - Algeria 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
MA - Marocco 2
PS - Palestinian Territory 2
PT - Portogallo 2
PY - Paraguay 2
SA - Arabia Saudita 2
SN - Senegal 2
UA - Ucraina 2
AM - Armenia 1
BE - Belgio 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MG - Madagascar 1
OM - Oman 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
ZM - Zambia 1
Totale 2.483
Città #
Ashburn 173
Singapore 158
San Jose 107
Hong Kong 83
Chandler 75
Fairfield 49
Los Angeles 38
Nyköping 38
Helsinki 34
Beijing 33
Seattle 27
Woodbridge 27
Lauterbourg 24
New York 23
Bari 22
Houston 22
Moscow 21
Cambridge 20
Wilmington 19
Falkenstein 17
Council Bluffs 16
Ho Chi Minh City 16
Munich 16
Dallas 15
Abidjan 14
Lawrence 14
Giza 13
Hanoi 13
London 13
Paris 13
São Paulo 13
Hyderabad 12
Rome 12
Jakarta 11
Redwood City 11
Roxbury 11
Toronto 10
Warsaw 10
Buffalo 9
Amsterdam 8
Chicago 8
Heerlen 8
Santa Clara 8
Tokyo 8
Trinitapoli 8
Atlanta 7
Baghdad 7
Milan 7
Montreal 7
Orem 7
Mexico City 6
Nuremberg 6
Rio de Janeiro 6
San Diego 6
Turku 6
Vienna 6
Denver 5
Des Moines 5
Haiphong 5
Inglewood 5
Manchester 5
Phoenix 5
Poplar 5
Princeton 5
Querétaro 5
The Dalles 5
Barnet 4
Belo Horizonte 4
Berlin 4
Cairo 4
Chennai 4
City of London 4
Dearborn 4
Ottawa 4
Porto Alegre 4
Redmond 4
Verona 4
Ankara 3
Ann Arbor 3
Barueri 3
Biên Hòa 3
Boston 3
Brooklyn 3
Curitiba 3
Frankfurt am Main 3
Greensboro 3
Guarulhos 3
Kingston 3
Lagos 3
Lima 3
Mumbai 3
Nanjing 3
Naples 3
New Delhi 3
Perth 3
Recife 3
Roubaix 3
San Francisco 3
Schiffdorf 3
Slough 3
Totale 1.534
Nome #
Diabetes and cancer: pathophysiological fundamentals of a 'dangerous affair' 182
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes Trials 164
Diabetic foot: clinical approach 147
Efficacy and Safety of Different Hybrid Closed Loop Systems for Automated Insulin Delivery in People With Type 1 Diabetes: A Systematic Review and Network Meta-Analysis 144
Cardiovascular and Renal Effectiveness of GLP-1 Receptor Agonists vs. Other Glucose-Lowering Drugs in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Real-World Studies 131
Commentary: Glucose control: Not just a bystander in GLP-1RA-mediated cardiovascular protection 124
Thyroid and shoulder diseases: the bases of a linked channel 123
Reduction of hypoglycaemia, lifestyle modifications and psychological distress during lockdown following SARS-CoV-2 outbreak in type 1 diabetes 112
Diabetes in the Time of COVID-19: A Twitter-Based Sentiment Analysis 101
Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis 95
Professional continuous glucose monitoring in patients with diabetes mellitus: A systematic review and meta-analysis 88
Mini Review: Effect of GLP-1 Receptor Agonists and SGLT-2 Inhibitors on the Growth Hormone/IGF Axis 87
GLP-1 Receptor Agonists for Cardiovascular Protection: A Matter of Time 85
Role of glucose-lowering medications in erectile dysfunction 85
Effectiveness and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in type 2 diabetes: an Italian cohort study 84
Glucagon in type 2 diabetes: Friend or foe? 81
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database 81
Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure 78
The diabetic lung: An easy target for SARS-CoV-2? 75
Pharmacological modulation of adaptive thermogenesis: new clues for obesity management? 75
New insights into the treatment of non-healing diabetic foot ulcers 73
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future 73
SGLT-2 inhibitors as cardio-renal protective agents 72
Titratable fixed-ratio combination of insulin glargine plus lixisenatide: A simplified approach to glycemic control in type 2 diabetes mellitus 66
Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials 54
Efficacy and safety of once-weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta-analysis 43
Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure? 41
Effectiveness of GLP-1RA according to different type 2 diabetes phenotypes: A retrospective study 36
Totale 2.600
Categoria #
all - tutte 11.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202120 0 0 0 0 0 0 0 0 0 10 9 1
2021/202290 7 0 1 3 0 7 2 4 17 19 10 20
2022/2023190 16 35 16 14 10 26 8 22 28 0 9 6
2023/202492 15 22 6 10 18 12 1 2 0 2 1 3
2024/2025575 12 5 16 20 30 72 64 79 22 17 93 145
2025/20261.411 197 83 92 201 206 106 133 48 178 167 0 0
Totale 2.600